Showing 4,741 - 4,760 results of 4,913 for search '"Hodgkin's lymphoma"', query time: 0.41s Refine Results
  1. 4741

    Primary splenic anaplastic variant of diffuse large B-cell lymphoma: a case report by Sawsan Ismail, Filip Ali, Hussein Ajamieh, Samir Kanaan, Rana Issa, Ali Daoud, Zuheir Alshehabi

    Published 2021-05-01
    “…Abstract Background Primary splenic lymphoma represents a rare entity that constitutes less than 1% of non-Hodgkin lymphomas, and less than 2% of all lymphomas. Diffuse large B-cell lymphoma (DLBCL) is the most common histological subtype of primary splenic lymphomas. …”
    Get full text
    Article
  2. 4742

    Aggressive primary gastric lymphoma (PGL) masquerading as hepatocellular cancer (HCC) in alcoholic cirrhosis by Moiz Ahmed, Ahmed Al-Khazraji, Umer Syed, Tasur Seen, Aaron Walfish

    Published 2021-03-01
    “…Abstract Background The gastrointestinal tract is sa well-known site for extranodal Non-Hodgkin lymphomas, with the stomach is known to be the most common site on lymphoma, primary gastric lymphoma (PGL). …”
    Get full text
    Article
  3. 4743

    Aspartame Safety as a Food Sweetener and Related Health Hazards by Shurooq Asaad Abdulameer Shaher, Dan Florin Mihailescu, Bogdan Amuzescu

    Published 2023-08-01
    “…Epidemiology studies also evidenced associations between daily aspartame intake and a higher predisposition for malignant diseases, like non-Hodgkin lymphomas and multiple myelomas, particularly in males, but an association by chance still could not be excluded. …”
    Get full text
    Article
  4. 4744

    Spectrum of Radiological Manifestations in Lymphoproliferative Malignancies with Unusual Extra Nodal Soft Tissue Involvement by Shantiranjan Sanyal, Akhila Prasad, Lalendra Upreti, Umesh Chandra Garga

    Published 2016-07-01
    “…Lymphoproliferative malignancies constitute a wide spectrum of haematological malignancies and their prevalence is widely increasing. Non-Hodgkin lymphomas and Hodgkin disease, frequently involve extranodal soft tissue structures in the head and neck, thorax and abdomen. …”
    Get full text
    Article
  5. 4745

    Anaplastic Large Cell Lymphoma with Generalized Skin Lesion in Childhood: Clinical Case by Timur T. Valiev, Tatyana S. Belysheva, Svetlana R. Varfolomeeva

    Published 2020-12-01
    “…Anaplastic large cell lymphoma (ALCL) represents 15% of all non-Hodgkin lymphomas (NHL) in children, and it is characterized by aggressive course and involvement of various organs and systems (including skin) in the pathological process. …”
    Get full text
    Article
  6. 4746

    Translational Applications of Artificial Intelligence and Machine Learning for Diagnostic Pathology in Lymphoid Neoplasms: A Comprehensive and Evolutive Analysis by Julia Moran-Sanchez, Antonio Santisteban-Espejo, Miguel Angel Martin-Piedra, Jose Perez-Requena, Marcial Garcia-Rojo

    Published 2021-05-01
    “…Thematically, current research is focused on the integration of digital image analysis and genomic sequencing in Non-Hodgkin lymphomas, prediction of chemotherapy response and validation of new prognostic models. …”
    Get full text
    Article
  7. 4747

    Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review by Andrea Rivero, Andrea Rivero, Pablo Mozas, Pablo Mozas, Laura Magnano, Laura Magnano, Armando López-Guillermo, Armando López-Guillermo, Armando López-Guillermo

    Published 2023-05-01
    “…Although mostly incurable, indolent non-Hodgkin lymphomas (iNHL) are chronic diseases with a median overall survival approaching 20 years. …”
    Get full text
    Article
  8. 4748

    Targeting the DNA Damage Response to Increase Anthracycline-Based Chemotherapy Cytotoxicity in T-Cell Lymphoma by Martina Magni, Chiara Paolizzi, Chiara Monfrini, Cristina Vella, Paolo Corradini, Cristiana Carniti

    Published 2022-03-01
    “…Mature T-cell lymphomas (MTCLs) represent a heterogeneous group of aggressive non-Hodgkin lymphomas comprising different entities. Anthracycline-based regimens are considered the standard of care in the front-line treatment. …”
    Get full text
    Article
  9. 4749

    Polymorphism of autoimmune encephalitis by Evgeny L. Polonskii, Dmitriy I. Skulyabin, Sergey V. Lapin, Igor V. Krasakov, Olga V. Tikhomirova, Vladimir D. Nazarov, Anna N. Моshnikova, Igor V. Litvinenko, Irina M. Slashcheva, Natalia T. Mamatova, Natalia I. Zakharova, Natalia A. Sokolova, Alexandra V. Маzing, Alexandra V. Lyamina, Yulia B. Belozerova

    Published 2019-06-01
    “…The first patient was diagnosed with a cross-autoimmune syndrome with a combination of Hodgkins lymphoma and anti-NMDA encephalitis, probably triggered by the reactivation of the EpsteinBarr virus with a fatal outcome. …”
    Get full text
    Article
  10. 4750

    Multifocal Colonic Ulcerations: An Unusual Presentation of Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma by Vítor Macedo Silva, Marta Freitas, Pedro Boal Carvalho, Francisca Dias de Castro, José Cotter

    Published 2021-04-01
    “…Introduction: Mucosa-associated lymphoid tissue (MALT) lymphoma is relatively uncommon and accounts for only 5% of all non-Hodgkin lymphomas. The most common site of extranodal involvement is the gastrointestinal (GI) tract, with most cases affecting the stomach (up to 75% of all GI MALT lymphomas). …”
    Get full text
    Article
  11. 4751

    Recurrent Mantle Cell Lymphoma Presenting as Gastrointestinal Bleeding by Rafeeq Ahmed, Kishore Kumar, Jasbir Makker, Masooma Niazi, Bhavna Balar

    Published 2018-08-01
    “…Mantle cell lymphoma is a rare and aggressive subtype of B-cell non-Hodgkin lymphomas. Mantle cell lymphoma frequently involves extranodal sites, and gastrointestinal tract is involved microscopically and macroscopically in more than 80% of cases. …”
    Get full text
    Article
  12. 4752

    Targeted alpha anticancer therapies: update and future prospects by Allen BJ, Huang CY, Clarke RA

    Published 2014-11-01
    “…Clinical trial outcomes are reviewed for neuroendocrine tumors, leukemia, glioma, melanoma, non-Hodgkins lymphoma, and prostate bone metastases. Recommendations and future directions are proposed.Keywords: biodosimetry, microdosimetry, mutagenesis, PAI2, bevacizumab, C595, J591, tumors, cancer, metastases…”
    Get full text
    Article
  13. 4753

    Lennert′s lymphoma: Clinicopathological profile of five cases by Sarda Parimal, Rekha Pai, Marie Therese Manipadam, Sheila Nair

    Published 2013-01-01
    “…Conclusions: Lennert′s lymphoma constituted 0.11% of all non-Hodgkin lymphomas (NHLs) in our institution. Differentiation from classical Hodgkin′s lymphoma is sometimes difficult by morphology and immunohistochemistry alone and TCR gene rearrangement was extremely useful in diagnosis.…”
    Get full text
    Article
  14. 4754

    Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas by Rahul S. Bhansali, Stefan K. Barta

    Published 2023-02-01
    “…Non-Hodgkin lymphomas (NHL) are cancers of mature B-, T-, and NK-cells which display marked biological heterogeneity between different subtypes. …”
    Get full text
    Article
  15. 4755

    Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle? by Moussab Tatfi, Olivier Hermine, Felipe Suarez

    Published 2019-01-01
    “…However, immunocompromised patients may be unable to control EBV infection and are at increased risk of EBV-related malignancies, such as diffuse large B-cell lymphomas or Hodgkin's lymphomas. Ataxia telangiectasia (AT) is a primary immunodeficiency caused by mutations in the ATM gene and associated with an increased incidence of cancers, particularly EBV-associated lymphomas. …”
    Get full text
    Article
  16. 4756

    Inflammasomes—New Contributors to Blood Diseases by Jaromir Tomasik, Grzegorz Władysław Basak

    Published 2022-07-01
    “…The NLRP3 inflammasome correlated with the pathogenesis of non-Hodgkin lymphomas, multiple myeloma, acute myeloid leukemia, lymphoid leukemias, myelodysplastic neoplasms, graft-versus-host-disease, and sickle cell anemia. …”
    Get full text
    Article
  17. 4757

    CAR-T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and Hope by Georg Hopfinger, Ulrich Jäger, Nina Worel

    Published 2019-04-01
    “…Patients with non-Hodgkin lymphomas (NHLs) resistant to standard therapies have a dismal prognosis. …”
    Get full text
    Article
  18. 4758

    Serologic detection of diffuse large B-cell lymphoma-associated antigens. by Liggins, A, Guinn, B, Hatton, C, Pulford, K, Banham, A

    Published 2004
    “…Diffuse large B-cell lymphoma (DLBCL) accounts for 30-40% of all adult non-Hodgkin's lymphomas, yet the understanding of its underlying genetic abnormalities remains poor. …”
    Journal article
  19. 4759

    Applying population mechanistic modelling to find determinants of CAR-T dynamics in month-one lymphoma patients by Brown, L, McConnell, M, Rosler, R, Peiser, L, Schmidt, B, Ratushny, A, Gaffney, E, Coles, M

    Published 2024
    “…Chimeric Antigen Receptor (CAR) T-cells have been utilised for the treatment of several malignancies, including Non-Hodgkin Lymphomas (NHL). A myriad of product- and patient-specific factors determine the extent of patient response, and determining which are most impactful requires analysis of clinical data. …”
    Journal article
  20. 4760

    Paternal occupational contact level and childhood leukaemia in rural Scotland: a case-control study. by Kinlen, L, Bramald, S

    Published 2001
    “…In a national Scottish study of 809 cases of leukaemia and non-Hodgkins lymphoma diagnosed in 1950-89 among children aged 0-4 years who were born in Scotland, together with 2363 matched population controls, we investigated one aspect of the infective hypothesis. …”
    Journal article